FDA authorizes nonemergency use of at-home dual COVID-19, flu test

The U.S. Food and Drug Administration announced that it has granted marketing authorization for use of the combination COVID-19 and influenza test without the required emergency use declaration.

The over-the-counter test is designed for at-home self-administration in individuals aged 14 years and older experiencing respiratory symptoms and is capable of detecting proteins present in both disease-causing viruses. Individuals aged 2 to 13 years require adults to administer the tests.

The FDA hopes its authorization can improve access to COVID-19 and flu infection diagnoses. Individuals who continue to experience lingering symptoms of either infection after testing negative were advised to seek medical attention.

Read more: FDA

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.